Multiplex real-time PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis
Background and Objective: Rapid diagnosis of pertussis is important for the timely isolation of the infection source and early prevention measures among the contact persons, especially among non-vaccinated infants for whom pertussis is life- threatening.
Materials and Methods: Targets IS481, IS1001, BP0026 and human GAPDH gene were used to develop a multiplex real- time PCR assay based on the TaqMan technology for detection and identification of Bordetella pertussis and Bordetella parapertussis in clinical samples. A total of 121 human clinical specimens obtained within 2012-2013 were used to evaluate the multiplex real-time PCR assay. Clinical specimens were also tested for culture and conventional PCR. Sensitivity and specificity for culture, conventional PCR, and multiplex real-time PCR were measured in comparison with a clinical standard for B. pertussis infection.
Results: The lower limit of detection (LLOD) of the multiplex assay was similar to the LLOD of each target in an individual assay format, which was approximately 1 genomic equivalent per reaction for IS481, IS1001 and 10 genomic equivalents per reaction for BP0026 target. When the B. pertussis assays were compared with a clinical standard for B. pertussis infection, sensitivity was 5, 59 and 89% the specificity was 100, 100 and 100% for culture, conventional PCR, and multiplex real-time PCR, respectively.
Conclusions: Developed multiplex real-time PCR offers a fast tool with high sensitivity and specificity for the diagnosis of B. pertussis and B. parapertussis infections which is suitable for implementation in a routine laboratory diagnostics.
Melker HE ,Schellekens JF, Neppelenbroek SE, Mooi FR, Rumke HC, Conyn-van Spaendonck MA: Reemer- gence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data.Emerg Infect Dis 2000; 6: 348–357.
Rendi-Wagner P, Kundi M, Mikolasek A, Vecsei A, Fruhwirth M, Kollaritsch H: Hospital-based active sur- veillance of childhood pertussis in Austria from 1996 to 2003: Estimates of incidence and vaccine effective- ness of whole-cell and acellular vaccine. Vaccine 2006;24:5960–5965.
Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE, EUVAC-NET Group: Resurgence of pertus- sis in Europe. Pediatr Infect Dis J 2005; 24:761–765.
Birkebaek NH: Bordetella pertussis in the etiology of chronic cough in adults.Diagnostic methods and clinic. Dan Med Bull 2001; 48:77–80.
Wendelboe and Van Rie: Diagnosis of pertussis: a his- torical review and recent developments. Expert Rev Mol Diagn 2006; 6: 857–864.
Loeffelholz MJ, Thompson CJ, Long KS, and Gil- christ MJ: Comparison of PCR, culture, and direct ﬂuorescent-antibody testing for detection of Bordetella pertussis. J Clin Microbiol 1999; 37:2872–2876.
Tilley PA, Kanchana MV, Knight I, Blondeau J, Anton- ishyn N, and Deneer H: Detection of Bordetella per- tussis in a clinical laboratory by culture, polymerase chain reaction, and direct ﬂuorescent antibody staining; accuracy and cost. Diagn Microbiol Infect Dis 2000;37:17–23.
Anonymous: Investigation of specimens for Bordetella species. Health Protection Agency Standard Operating Procedure (BSOP 6i5.1), 2003, London, UK.
Kerr JR., Matthews RC: Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Eur J Clin Microbiol Infect Dis 2000; 19:77–88.
Melker HE, Versteegh FG, Conyn-Van Spaendonck MA, Elvers LH, Berbers GA, van Der Zee A, Schelle- kens JFP: Specificity and sensitivity of high levels of immunoglobuline G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 2000; 38.800–806.
Kosters K, Riffelmann M, Dohrn B, Wirsing von Konig CH: Comparison of Five Commercial Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Bordetella pertussis. Clin Diagn Lab Immunol 2000;7:422–426.
Houard S, Hackel C, Herzog A, Bollen A: Specific identification of Bordetella pertussis by polymerase chain reaction. Res Microbiol 1989; 140:477–487.
Douglas E, Coote GJ, Parton R, McPheat W:. Identifi- cation of Bordetella pertussis in nasopharyngeal swabs by PCR amplification of a region of the adenylate cy- clase gene. J Med Microbiol 1993; 38:140–144.
Fry NK, Tzivra O, Ting Li Y, McNiff A, Doshi N, , Ma- ple PAC, Crowcroft NS, , Miller E, George RC, Har- rison TG: Laboratory diagnosis of pertussis infections: the role of PCR and serology. J Med Microbiol 2004,53: 519–525.
Reizenstein E, Lindberg L, Mollby R,. Hallander HO: Validation of nested Bordetella PCR in pertussis vac- cine trial. J Clin Microbiol 1996; 34:810–815.
Stark M, Reizenstein E, Uhlen M, Lundeberg J: Im- munomagnetic separation and solid-phase detection of Bordetella pertussis. J Clin Microbiol 1996; 34: 778–784.
Nygren M,. Reizenstein E,. Ronaghi M,.Lundeberg J: Polymorphism in the Pertussis Toxin Promoter Region Affecting the DNA-Based Diagnosis of Bordetella In- fection. J Clin Microbiol 2000; 38: 55–60.
Stefanelli P, Giuliano M, Bottone M, Spigaglia P, Mas- trantonio P: Polymerase chain reaction for the identifi- cation of Bordetella pertussis and Bordetella paraper- tussis. Diagn Microbiol Infect Dis 1996, 24:197−200.
Makinen J, Viljanen MK, Mertsola J, Arvilommi H, He Q: Rapid identification of Bordetella pertussis pertactin gene variants using Lightcycler real-time polymerase chain reaction combined with melting curve analy- sis and gel electrophoresis. Emerg Infect Dis 2001; 7:952−958.
Knorr L, Fox JD, Tilley PA, Ahmed-Bentley J: Evalu- ation of real-time PCR for diagnosis of Bordetella per- tussis infection. BMC Infect Dis 2006; 6: 62–67.
Farrell DJ, McKeon M, Daggard G, Loeffelholz MJ, Thompson CJ, Mukkur TKS: Rapid-Cycle PCR meth- od to detect Bordetella pertussis that fulfills all consen- sus recommendations for use of PCR in diagnosis of pertussis. J Clin Microbiol 2000; 38: 4499–4502.
Qin X, Galanakis E, Martin ET, Englund JA: Multitar- get PCR for Diagnosis of Pertussis and Its Clinical Im- plications. J Clin Microbiol 2007; 45: 506–511.
Register K, Nicholson TL: Misidentification of Bor- detella bronchiseptica as Bordetella pertussis using a newly described real-time PCR targeting the pertactin gene. J Med Microbiol 2007; 56: 1608–1610.
Vincart B, De Mendonca R, Rottiers S, Vermeulen F, Struelens MJ, Denis O: A specific real-time PCR assay for the detection of Bordetella pertussis. J Med Micro- biol 2007; 56:918−920.
Farrell DJ, Daggard G, Mukkur TK: Nested duplex PCR to detect Bordetella pertussis and Bordetella par- apertussis and its application in diagnosis of pertussis in nonmetropolitan Southeast Queensland, Australia. J Clin Microbiol 1999; 37:606–610.
Glare EM, Paton JC, Premier RR, Lawrence AJ, Nisbet IT: Analysis of a repetitive DNA sequence from Bor- detella pertussis and its application to the diagnosis of pertussis using the polymerase chain reaction. J Clin Microbiol 1990; 28:1982−1987.
Van der Zee A, Agterberg C, Peeters M, Schellekens J, Mooi FR: Polymerase chain reaction assay for pertus- sis: simultaneous detection and discrimination of Bor- detella pertussis and Bordetella parapertussis. J Clin Microbiol 1993; 31:2134−2140.
Templeton KE, Scheltinga SA, van der Zee A, Diederen BM, van Kruijssen AM, Goossens H, Ed Kuijper, Claas Eric CJ: Evaluation of Real-Time PCR for Detection of and Discrimination between Bordetella pertussis, Bor- detella parapertussis, and Bordetella holmesii for Clin- ical Diagnosis. J Clin Microbiol 2003; 41:4121–4126.
Riffelmann M.,Wirsing von Konig CH, Caro V, Guiso N: Nucleic acid amplification test for diagnosis of Bor- detella infections. J. Clin. Microbiol 2005, 43:4925–4929.
Kalloen T, Qiushui He: Bordetella pertussis strain vari- ation and evolution postvaccination. Expert Rev Vac- cines 2009; 8:863-875.
Sloan LM, Hopkins MK, Mitchell PS, Vetter EA Rosenblatt JE, Harmsen WS, Cockerill FR, Patel R: Multiplex LightCycler PCR Assay for Detection and Differentiation of Bordetella pertussis and Bordetella parapertussis in Nasopharyngeal Specimens. J Clin Microbiol 2002; 40:96–100.
Kosters K, Reischl U, Schmetz J, Riffelmann M, von Konig WCH: Real-Time LightCycler PCR for De- tection and Discrimination of Bordetella pertussis and Bordetella parapertussis J Clin Microbiol 2002;40:1719–1722.
Xu Y, Hou Q, Yang R, Zhang S: Triplex real-time PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis. The Authors Journal Compilation APMIS 2010, 118:685–691.
Tondella ML, Carlone GM, Messonnier N, Quinn CP, Meade BD, Burns DL, et al. International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Pre- vention, Atlanta, Georgia, United States, 19-20 July 2007.Vaccine 27:803-814.
WHO, Department Vaccines and Biologicals: WHO- recommended standards for surveillance of selected vaccine-preventable diseases. 2003.
Tatti KM, Sparks KN, Boney KO, Tondella ML: Novel Multitarget Real-Time PCR Assay for Rapid Detection of Bordetella Species in Clinical Specimens. J Clin Mi- crobiol 2011, 49:4059–4066.
Probert WS, Ely J, Schrader K, Atwell J, Nossoff A, Kwan S: Identification and Evaluation of New Tar- get Sequences for Specific Detection of Bordetella pertussis by Real-Time PCR. J Clin Microbiol 2008; 46:3228-3231.
Register KB, Sanden GN: Prevalence and sequence variants of IS481 in Bordetella bronchiseptica: impli- cations for IS481-based detection of Bordetella pertus- sis. J Clin Microbiol 2006; 44:4577–4583.
Menard A, Lehours P, Sarlangue J, Bebear C, Me- graud F, de Barbeyrac B: Development of a real-time PCR for the identification of Bordetella pertussis and Bordetella parapertussis. Clin Microbiol Infect 2007;134:419–423.
|Issue||Vol 6 No 3 (2014)|
|Bordetella parapertussis Bordetella pertussis Multiplex real-time PCR diagnosis|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|